学术探索
学术期刊
新闻热点
数据分析
智能评审

Pro: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery

被引：13
作者：
Body, Simon C.
Mazer, C. David
机构：
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Anesthesia Perioperat & Pain Med, Boston, MA 02115 USA
[2] Univ Toronto, St Michaels Hosp, Dept Anesthesia, Toronto, ON M5B 1W8, Canada
来源：
ANESTHESIA AND ANALGESIA | 2006年 / 103卷 / 06期
关键词：
D O I：
10.1213/01.ane.0000246810.88697.15
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：1354 / 1359
页数：6
相关论文
共 46 条
  • [1] Analyses of coronary graft patency after aprotinin use: Results from the international multicenter aprotinin graft patency experience (IMAGE) trial
    Alderman, EL
    Levy, JH
    Rich, JB
    Nili, M
    Vidne, B
    Schaff, H
    Uretzky, G
    Pettersson, G
    Thiis, JJ
    Hantler, CB
    Chaitman, B
    Nadel, A
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 116 (05) : 716 - 729
  • [2] Total arterial revascularization is safe: Multicenter ten-year analysis of 71,470 coronary procedures
    Baskett, RJF
    Cafferty, FH
    Powell, SJ
    Kinsman, R
    Keogh, BE
    Nashef, SAM
    [J]. ANNALS OF THORACIC SURGERY, 2006, 81 (04) : 1243 - 1248
  • [3] APROTININ THERAPY IN CARDIAC OPERATIONS - A REPORT ON USE IN 41 CARDIAC CENTERS IN THE UNITED-KINGDOM
    BIDSTRUP, BP
    HARRISON, J
    ROYSTON, D
    TAYLOR, KM
    TREASURE, T
    [J]. ANNALS OF THORACIC SURGERY, 1993, 55 (04) : 971 - 976
  • [4] Bohrer H, 1990, J Cardiothorac Anesth, V4, P222, DOI 10.1016/0888-6296(90)90241-7
  • [5] Pharmacokinetics of ε-aminocaproic acid in patients undergoing aortocoronary bypass surgery
    Butterworth, J
    James, RL
    Lin, YG
    Prielipp, RC
    Hudspeth, AS
    [J]. ANESTHESIOLOGY, 1999, 90 (06) : 1624 - 1635
  • [6] Are antifibrinolytic drugs equivalent in reducing blood loss and transfusion in cardiac surgery? A meta-analysis of randomized head-to-head trials
    Carless P.A.
    Moxey A.J.
    Stokes B.J.
    Henry D.A.
    [J]. BMC Cardiovascular Disorders, 5 (1)
  • [7] APROTININ THERAPY FOR REOPERATIVE MYOCARDIAL REVASCULARIZATION - A PLACEBO-CONTROLLED STUDY
    COSGROVE, DM
    HERIC, B
    LYTLE, BW
    TAYLOR, PC
    NOVOA, R
    GOLDING, LAR
    STEWART, RW
    MCCARTHY, PM
    LOOP, FD
    [J]. ANNALS OF THORACIC SURGERY, 1992, 54 (06) : 1031 - 1038
  • [8] Aprotinin in primary valve replacement end reconstruction: A multicenter, double-blind, placebo-controlled trial
    DAmbra, MN
    Akins, CW
    Blackstone, EH
    Bonney, SL
    Cohn, LH
    Cosgrove, DM
    Levy, JH
    Lynch, KE
    Maddi, R
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 112 (04) : 1081 - 1089
  • [9] Clinical inhibition of the seven-transmembrane thrombin receptor (PAR1) by intravenous aprotinin during cardiothoracic surgery
    Day, JRS
    Punjabi, PP
    Randi, AM
    Haskard, DO
    Landis, RC
    Taylor, KM
    [J]. CIRCULATION, 2004, 110 (17) : 2597 - 2600
  • [10] Anaphylactic reactions to aprotinin reexposure in cardiac surgery -: Relation to antiaprotinin immunoglobulin G and E antibodies
    Dietrich, W
    Späth, P
    Zühlsdorf, M
    Dalichau, H
    Kirchhoff, PG
    Kuppe, H
    Preiss, DU
    Mayer, G
    [J]. ANESTHESIOLOGY, 2001, 95 (01) : 64 - 71
12345